Sec. 38a-542a. Cancer clinical trials: Coverage for routine patient care costs.
Sec. 38a-542a. Cancer clinical trials: Coverage for routine patient care costs.
Each group health insurance policy providing coverage of the type specified in subdivisions (1), (2), (4), (11) and (12) of section 38a-469 delivered, issued for delivery or
renewed in this state on or after January 1, 2002, shall provide coverage for the routine
patient care costs, as defined in section 38a-542d, associated with cancer clinical trials,
in accordance with sections 38a-542b to 38a-542g, inclusive. As used in this section
and sections 38a-542b to 38a-542g, inclusive, "cancer clinical trial" means an organized,
systematic, scientific study of therapies, tests or other clinical interventions for purposes
of treatment or palliation or therapeutic intervention for the prevention of cancer in
human beings, except that a clinical trial for the prevention of cancer is eligible for
coverage only if it involves a therapeutic intervention and is a phase III clinical trial
approved by one of the entities identified in section 38a-542b and is conducted at multiple institutions.
(P.A. 01-171, S. 1, 25.)
History: P.A. 01-171 effective January 1, 2002.
See Sec. 38a-504a for similar provisions re individual policies.